Bionomics Ltd
ASX:BNO

Watchlist Manager
Bionomics Ltd Logo
Bionomics Ltd
ASX:BNO
Watchlist
Price: 0.01 AUD Market Closed
Market Cap: 13.5m AUD

Operating Margin
Bionomics Ltd

-10 129%
Current
-4 651%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-10 129%
=
Operating Profit
-26.7m
/
Revenue
263.6k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
Bionomics Ltd
ASX:BNO
14.7m AUD
-10 129%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
405.3B USD
33%
US
Amgen Inc
NASDAQ:AMGN
176.3B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
151B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.7B USD
28%
AU
CSL Ltd
ASX:CSL
83.3B AUD
26%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD
8%
NL
argenx SE
XBRU:ARGX
44.3B EUR
22%
No Stocks Found

Bionomics Ltd
Glance View

Market Cap
14.7m AUD
Industry
Biotechnology

Bionomics Ltd. is a clinical stage biopharmaceutical company. The firm is engaged in discovery and development of novel drug candidates focused on the treatment of central nervous system disorders. The firm's segment includes Drug discovery and development and Contract services. Drug discovery and development segment includes discovery, development, and commercialization of compounds to match a target product profile. Contract services segment includes provision of scientific services on a fee for service basis to both external and internal customers. Its product candidates include BNC210, BNC375, BNC101 and BNC105. The BNC210 provides treatment for anxiety disorders, co-morbid anxiety, and depression. The BNC375 is a molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease (AD).The Company operates in three geographical areas, such as Australia, France and United States of America.

BNO Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-10 129%
=
Operating Profit
-26.7m
/
Revenue
263.6k
What is the Operating Margin of Bionomics Ltd?

Based on Bionomics Ltd's most recent financial statements, the company has Operating Margin of -10 129%.

Back to Top